Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1196 results found. Search for [ Indian pharma companies ]

Results 1 to 21 of 1196
Dipak Mondal
New Delhi, November 19, 2019
The Company Law committee constituted by the ministry of corporate affairs in September this year has also recommended amending 46 penal provisions under the Companies Act to either remove criminality or to restrict the punishment to only fine in case of certain defaults committed by companies


PTI
November 18, 2019
Prasad said there was a need for the government to focus on and invest more in primary healthcare


Niti Kiran
November 14, 2019
An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India


Rashmi Pratap
November 13, 2019
Average market cap of BT 500 companies has fallen. Unless corporate earnings grow and performance of mid- and small-caps improves, there seems no recovery in sight.


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
November 11, 2019
Indian shares closed nearly flat on Monday after a choppy trading session, backed by gains in banking indices, that rose 1% to 1.3%. While BSE Sensex ended 21 points higher at Rs 40,345, NSE Nifty rose 5 points to closed at 11,913. Indian markets will be closed on Tuesday for a public holiday.Benchmark indices that started the day on a tepid note recovered from lossed bythe closing hour to end marginally higher today. Sensex and Nifty fell by the opening bell on Friday, and turn...


BusinessToday.In
November 8, 2019
Benchmark indices Sensex and Nifty fell 0.80% by the closing bell, backed by heavy selling pressure in pharma, FMCG, IT and metal stocks. While Sensex closed 330 points lower at 40,323 level, Nifty ended at 11,908, declining 103 points.While Sun Pharma, Vedanta, HUL and ONGC were the major losers by the closing hour, YES Bank, IndusInd Bank and ICICI Bank were among the top Sensex gainersWith the opening bell, equity market slipped in the red and turned volatile, after Moody's I...


Anand Adhikari
November 8, 2019
The State Bank of India (SBI) joins the list of marquee names such as behemoth Life Insurance Corporation (LIC) and the Canadian pension fund CDPQ to lend money to Piramal's $2 billion Group


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


PB Jayakumar
New Delhi, October 30, 2019
Robots are changing the world of surgery, including in India


BusinessToday.In
New Delhi, October 30, 2019
Sixteen CEOs and economists lay out a roadmap to revive the economy


Joe C Mathew
New Delhi, October 30, 2019
The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight


BusinessToday.In
October 29, 2019
While Sensex made an intraday high of 39,917, Nifty crossed 11,800 level for the first time since July 5 to touch 11,809.40 mark intraday.


Goutam Das
New Delhi, October 13, 2019
The company doesn't sell directly to bars. It markets via distributors. A well thought out distributor strategy has now made the company stand out in many parts of the southern market.


PTI
October 9, 2019



BusinessToday.In
October 9, 2019
The S&P BSE Sensex ended 645 points or 1.72% higher at 38,177, while NSE's Nifty50 index closed 187 points or 1.68% higher at 11,313 mark.


PB Jayakumar
October 4, 2019
Organised pharma retail in India is valued at $1.5 billion and is projected to grow 20 per cent annually over the next four years, aided by online pharmacy growth of more than 25 per cent, says the survey


PTI
October 3, 2019
\"Sreeji brings to Lupin over 20 years of significant domain expertise and global experience,\" Lupin said in a statement


PB Jayakumar
October 1, 2019
The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.


Reuters
New Delhi, September 27, 2019
The move comes after the USFDA asked the company to test the drug for indications of N-nitrosodimethylamine (NDMA) impurity, which the regulator says is a 'probable human carcinogen'


PAGES 1 OF 60  12345